Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects

by Maria Giovanna Lupo, Nicola Ferri
Published 2018-07-01

Current Evidence and Future Perspectives on Pharmacological Treatment of Calcific Aortic Valve Stenosis

by Maristella Donato, Nicola Ferri, Maria Giovanna Lupo, Elisabetta Faggin, Marcello Rattazzi
Published 2020-11-01

Naturally Occurring PCSK9 Inhibitors

by Maria Pia Adorni, Francesca Zimetti, Maria Giovanna Lupo, Massimiliano Ruscica, Nicola Ferri
Published 2020-05-01

The Emerging Role of Nutraceuticals in Cardiovascular Calcification: Evidence from Preclinical and Clinical Studies

by Maristella Donato, Elisabetta Faggin, Francesco Cinetto, Carla Felice, Maria Giovanna Lupo, Nicola Ferri, Marcello Rattazzi
Published 2021-07-01

The Modulation of PCSK9 and LDLR by Supercritical CO₂ Extracts of <i>Mentha longifolia</i> and Isolated Piperitone Oxide, an <i>In Vitro</i> Study

by Stefania Sut, Irene Ferrarese, Maria Giovanna Lupo, Nicola De Zordi, Elisa Tripicchio, Nicola Ferri, Stefano Dall’ Acqua
Published 2021-06-01

PCSK9 Induces Rat Smooth Muscle Cell Proliferation and Counteracts the Pleiotropic Effects of Simvastatin

by Maria Giovanna Lupo, Silvia Marchianò, Maria Pia Adorni, Francesca Zimetti, Massimiliano Ruscica, Maria Francesca Greco, Alberto Corsini, Nicola Ferri
Published 2021-04-01

PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma

by Silvano Fasolato, Sabrina Pigozzo, Patrizia Pontisso, Paolo Angeli, Massimiliano Ruscica, Edoardo Savarino, Sara De Martin, Maria Giovanna Lupo, Nicola Ferri
Published 2020-09-01

Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line

by Maria Giovanna Lupo, Noemi Biancorosso, Elisa Brilli, Germano Tarantino, Maria Pia Adorni, Greta Vivian, Marika Salvalaio, Stefano Dall’Acqua, Stefania Sut, Cédric Neutel, Haixia Chen, Alessandro Bressan, Elisabetta Faggin, Marcello Rattazzi, Nicola Ferri
Published 2020-02-01

Relationship between Circulating PCSK9 and Markers of Subclinical Atherosclerosis—The IMPROVE Study

by Daniela Coggi, Beatrice Frigerio, Alice Bonomi, Massimiliano Ruscica, Nicola Ferri, Daniela Sansaro, Alessio Ravani, Palma Ferrante, Manuela Damigella, Fabrizio Veglia, Nicolò Capra, Maria Giovanna Lupo, Chiara Macchi, Kai Savonen, Angela Silveira, Sudhir Kurl, Philippe Giral, Matteo Pirro, Rona Juliette Strawbridge, Bruna Gigante, Andries Jan Smit, Elena Tremoli, Mauro Amato, Damiano Baldassarre, on behalf of the IMPROVE Study Group
Published 2021-07-01